Future Health Care Equity ETF (GDOC)
NYSEARCA: GDOC · Real-Time Price · USD
39.14
0.00 (0.00%)
Nov 13, 2026, 11:55 AM EST - Market open
| Assets | $20.68M |
| Expense Ratio | 0.75% |
| PE Ratio | 38.21 |
| Forward PE | 24.07 |
| Shares Out | 525,000 |
| Dividend | $0.11 (0.29%) |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 11.02% |
| Volume | 12 |
| Open | 39.22 |
| Previous Close | 39.14 |
| Day's Range | 38.97 - 39.23 |
| 52-Week Low | 31.32 |
| 52-Week High | 39.70 |
| Beta | 0.74 |
| Holdings | 41 |
| Inception Date | Nov 9, 2021 |
About GDOC
Fund Home PageThe Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care stocks. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is issued by Goldman Sachs.
Asset Class Equity
Category Health
Stock Exchange NYSE Arca
Ticker Symbol GDOC
ETF Provider Goldman Sachs
Top 10 Holdings
53.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.26% |
| Johnson & Johnson | JNJ | 6.15% |
| UnitedHealth Group Incorporated | UNH | 5.69% |
| Merck & Co., Inc. | MRK | 4.86% |
| Edwards Lifesciences Corporation | EW | 4.63% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.99% |
| Thermo Fisher Scientific Inc. | TMO | 3.86% |
| Agilent Technologies, Inc. | A | 3.84% |
| AstraZeneca PLC | AZN | 3.37% |
| Guardant Health, Inc. | GH | 3.30% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2025 | $0.1133 | Dec 30, 2025 |
| Dec 23, 2024 | $0.00576 | Dec 30, 2024 |
| Dec 26, 2023 | $0.17894 | Jan 2, 2024 |
| Sep 26, 2022 | $0.00003 | Sep 30, 2022 |
Performance
GDOC had a total return of 8.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 0.25%.
News
Goldman Sachs is building on the disruptive investing theme with a trio of new ETFs
Goldman Sachs Group is offering investors new ways to seek equity gains from disruptive companies, with its asset management business launching three exchange-traded funds focused on secular growth tr...
5 years ago - Market Watch